ABSTRACT-The accuracy of data coded from the medical records of 985 patients from 22 major U.S. cancer centers was checked by recoding during 1978-81. The 29 items covered demographics, diagnosis, and therapy. Original codes were compared to recodes, and disagreements were classified as major or minor. The highest rate of major disagreements, 23%, was for stage of disease, followed by 10% for histology and 7% for site.
Many medical research studies depend on data abstracted from patient medical records. Although the usefulness of these studies is dependent on the accuracy of these data, the issue of accuracy is treated only sparsely in the literature. Accuracy is crucial for comparative studies when data are collected from a number of different centers. Such programs include clinical trials, such as the Southwestern Oncology Group; centralized tumor registries, such as the Surveillance, Epidemiology, and End Results Program; and multiinstitution screening programs, such as the Breast Cancer Detection and Demonstration Project. Good data collection in these programs is essential for drawing correct conclusions about incidence, survival, treatment efficacy, and patterns of care.
In this paper we report on accuracy of data collected in a large, multicenter cancer registry based on patient medical records. We compare codes originally submitted to the coordinating center with codes determined by expert reabstracting and recoding of the same patient records.
The literature includes a limited number of studies of data quality. The results specifically related to cancer concern the accuracy of site coding. We found one study of cancer codes and recodes. This was the 1978 study by Demlo et al. (1) comparing coding by private coding services, such as the Professional Activity Study, with recoding of the same records by specially trained technicians. For breast and lung cancer cases (the only cancer sites reported), codes and recodes disagreed on a three-digit site code for about 20% of the cases, corresponding to a 20% "major disagreement rate" in our study. Three articles compared hospital diagnosis with cause of death on the death certificates. A 1958 study by Dorn and Cutler (2) found that 18% of a population-based sample of cancers had a different major site group or a noncancer cause on the death certificate. A 1981 study by Percy et al. (3) found a 15% disagreement rate in cancer site between hospital abstracts and death certificates. In a 1982 study by Gittlesohn and Senning (4), a sample of death certificates listing a neoplastic disease as the cause of death was compared with hospital discharge diagnoses. Seventeen percent of the records showed a different organ or a nonneoplastic disease.
In a study related to our findings, Feigl et al. (5) sent the same set of 25 typed and standardized cancer patient charts to 18 of the cancer centers that are included in the present study. The charts were coded at the centers and returned. Compared to the standard code, which was the one most frequently used by the 18 centers, the rate of major disagreements was 1% for anatomic site, 14% for stage of disease, and 5% for histology. Rates for most other key items were under 5%. These disagreement rates are low, relative to what would be expected in routine field experience, due to the standardized format of the test charts and their easy recognition by coders as test charts.
Other studies report on the reliability of coding for conditions other than cancer: Herrmann et al. (6) , Hendrickson and Myers (7), Monson and Bond (8) , and Clum and Bowen (9) . Corn (10) reports on qualitycontrol programs used in several large abstractingcoding operations.
To improve the understanding of cancer coding, we present results of nearly 1,000 independent recodes of basic patient data routinely submitted to a statistical coordinating center from 22 cancer centers. We also present new methods for analyzing this type of data.
MATERIALS AND METHODS
The study was performed during 1977-81 by the CCPDS as part of its data quality-control program. The CCPDS was established in 1977 to collect selected patient information according to uniform definitions at all 22 U.S. Comprehensive Cancer Centers (see "Appendix" for list of centers). Admissions from July I, 1977, are included. Data were coded at each center and forwarded to the coordinating center at the Fred Hutchinson Cancer Research Center in Seattle. The data for each patient consist of 29 simplified items, including demographic characteristics, tumor description, therapy, and survival. The coding procedures followed one of three forms at the institutions: I) coding directly from the medical record; 2) coding from abstracts of medical records; 3) using direct coding for some items such as sex, race, and therapy, and abstracting followed by coding for more difficult items such as site, stage, and histology. In the present study of coding quality, we did not attempt to duplicate the coding practice of each center; the intent was simply to arrive at accurate recodes that could be compared to original codes.
From 1978 to 1981, we attempted to develop expert codes to compare with a sample of original codes from each center. We abstracted cases and coded from the abstracts, whether or not an institution used abstracting as a step in coding. Representatives from the coordinating center visited each cancer center and abstracted information from the original inpatient and outpatient records. The sample of cases had been randomly selected before the visit. Cases were restricted to those that had passed computer edit checks and had been newly diagnosed at each center. Both the original codes and the reabstracts used only material that was dated before the date of last contract with the patient, as indicated by the original coder.
Most of the centers contributed approximately 50 cases each, though centers that entered later contributed fewer than 50. Approximately 55,000 cases were eligible, of which 1.8% were sampled. The sample size Per center was not proportional to the number of eligible cases, since the major purpose of the study was to evaluate each institution with a minimal number of cases. The sampling fraction at centers varied from 0.6 to 8%, except for two centers with only a small number of patients on file, where the sampling fraction was 20 and 80%, respectively. These two centers register protocol patients only.
Recoding of cases was done by the coordinating center staff, who had written the coding guidelines in use at all centers. Two of these expert coders prepared independent sets of recodes on each case without reference to the original center codes. Subsequently, the expert coders and supervisory staff consulted about differences between the two sets of recodes. The expert coders prepared a final set of recodes, which were then compared to the original center codes. Differences between the codes were classified as major or minor. A report of disagreements between expert and original codes was sent to each center with opportunity for rebuttal. Following rebuttal the expert codes were changed to agree with the center codes if the center documented the fact that a difference came about either through an abstracting or coding error by the eXPert coder or because some relevant item of information had not been available to the reabstractor. For example, the original coder may have had access to a physician's follow-up letter regarding therapy for a particular case, but the letter was not included in the hospital records used by the reabstractor. In a few cases both the coordinating center codes and the original center codes were considered to be acceptable alternatives. These cases were kept as justifiable disagreements. One of us (G. G.) determined the frequency of justifiable disagreements by reviewing cases from the 1st year of reabstracting.
We left some cases out of our analysis, because certain cancer centers did not follow the coding guidelines for some items. These deviations were typically due to unavailability of the information required for coding; e.g., a patient's birthplace was not recorded in the medical record of some institutions. In our analysis of each item, only the cases where the standard guidelines were being followed are included. This number of cases varies by item.
Among the 29 items coded we singled out eight as "key items" being of special interest and importance in cancer research: site, stage, histology, initial therapy (surgery, radiation, and chemotherapy), admission date, and diagnosis date. The codes for these key items are noted in table 1, along with definitions and examples of major and minor disagreements. Definitions for the other 21 items, listed in table 2, reflect a similar level of detail.
We used two different methods to examine disagreement rates for an item (e.g., center) while controlling for the effects of a second item (e.g., site). We first used the method of direct standardization as described in many sources, including Fleiss (11). These rates were standardized to the entire group of study cases. We also used a stratified logistic regression model (12, 13) to find statistically significant differences in disagreement rates between categories (e.g., specific sites) of one item while controlling for other related items (e.g., center and stage).
RESULTS
A total of 985 cases were sampled and included in the study. The site distribution of the sample was very similar to that of all CCPDS newly diagnosed cases. The sample thus can be considered reflective. of all newly diagnosed cases submitted to the coordinating center. 
Agreement Rates by Item
Among 29 items, 23 had major disagreement rates of 5% or less, and all but three items had minor disagreement rates of 10% or less (table 2). In the following we shall mainly discuss major disagreements.
Stage of disease had the highest major disagreement rate among all items (23%), followed by histology (10%). Primary site had a major disagreement rate of 7%. The high disagreement rate of stage probably reflects the larger number of reports that have to be reviewed to determine stage.
In site, stage, and histology coding, use of "unknown" codes and nonspecific codes versus more specific codes caused a large fraction of the disagreements. About half of the 215 stage major disagreements, more than one-third of the 101 histology major disagreements, and about one-fifth of the 70 site major disagreements were of this type. For other key items, use of the unknown code caused few or no major disagreements. The coding of unknown stage was particularly troublesome. In the 67 cases analyzed in which the centers used this code, fully 81 % had a major disagreement. Among the remaining stage major disagreements, there was also a tendency for the original center to code a lower stage, indicating less severe disease, than the coordinating center code. In site coding, about one-fifth of the major disagreements involved use of adjacent sites (e.g., stomach vs. distal esophagus).
Among disagreements involving the eight key items noted in table 1, 41% of the major disagreements occurred in stage alone and 71 % occurred in one of the "big three" items-site, stage, and histology. We found that the disagreement rates over a 2-year time-trend period were remarkably constant for the pooled eight key items.
Disagreements tended to cluster on certain cases leaving more cases free of major disagreements than might have been expected by chance alone. Fifty-eight percent of the cases were free of major disagreements in any of the eight key items, whereas 48% would have been expected by chance alone, a highly significant difference (P<.OOOI).
The last column of table 2 shows the number of cases for each item. Any departure from the maximum of 985 cases occurs where centers followed local coding practices rather than the standard guidelines. Among key items, only stage and date of diagnosis involved local coding variations, but less than 10% of the cases are affected for each item.
Disagreements Versus Errors
Each disagreement in the earliest half of the 985 cases was reviewed by one of us (G. G.), who was also coauthor of the coding guidelines, to determine how frequently both codes of a disagreement were acceptable. If both codes were acceptable, then the disagreement reflects justified differences in interpretation. If both codes are not acceptable, then the disagreement represents a coding error. Codes, recodes, reabstracts, and rebuttal statements from centers were reviewed for this purpose. We found that only 10 of 315 major disagreements in key items represented justified differences in interpretation between coders, and only 6 of 259 minor disagreements were justified. Thus almost all disagreements represented errors in coding. Site had 4 of 32 disagreements considered justified, the largest proportion (13%) of any item. We found that the unjustified disagreements or errors were usually due to information being missed by the original coder. Our rate of justified disagreements is consistent with our earlier, related study, where only 15 of 96 disagreements (16%) in stage codes were justified (5).
Groups of Items
Items are usually used in groups for tumor description or other purposes. Table 3 indicates several such common groups. In describing a tumor by site, stage, and histology, only about two-thirds of the cases can be expected to be free of major disagreements on the three items. This low rate is mainly due to the large disagreement rate for stage. The other groups of items show moderately high to high percentages of completely "clean" cases.
Multiple Sources of Disagreements
We found that disagreement rates varied widely by center, site, and stage. It was desirable to analyze disagreement rates for each of these factors while JNCI, VOL. 72, NO. 5, MAY 1984 controlling for the others, since, for example, each center might have a different mix of sites to code, implying a different average level of difficulty. We did a logistic regression analysis which controlled for this confounding effect.
For this analysis we calculated a new combined disagreement rate. This rate was the proportion of cases with a disagreement in at least one of the three tumor description items-site, stage, and histology. These three items are most commonly used in cancer research and are often used together. We studied the effect of site, stage, and center on the combined disagreement rate. We did not, however, study the effect of histology because of the large number of distinct histologies that would have to be considered. Of 985 cases, 46 that involved use of a nonstandard stage code were excluded. Sixty-seven other cases with unknown stage were also removed from that analysis, since, as noted earlier, the coding of unknown stage was a unique and clearly identifiable problem.
We found that site, center, and stage all significantly affected disagreement rates. We rejected the hypothesis of no site effect on the combined disagreement rate at p= .00004 in a logistic regression analysis stratified by center and stage. We also rejected the hypothesis of no center effect on the combined disagreement rate at p= .015 in an analysis stratified by site and stage. Finally, we rejected the hypothesis of no stage effect at P= .004, in an analysis stratified by site. The analysis of stage, which included 837 cases, controlled only for site, since controlling for center and site simultaneously led to a severe loss of power because of small numbers of cases in various strata. From the stage analysis we also excluded lymphoma cases staged using the Ann Arbor classification system; its categories do not correspond to solid tumor staging.
The combined disagreement rates by site are presented in table 4. The directly standardized rates adjust for the effect of centers. We used the number of cases by center for all sites combined as the standard. Sites with particularly high disagreement rates are esophagus, small intestine combined with the residual group "other digestive organs," and unknown and ill-defined sites. Low rates occurred for urinary system, rectum, leukemia, and the residual group "other specified sites." For some sites, the difference between standardized and crude rates in table 4 is large. The rates for buccal cavity and pharynx, soft tissue, and other female genital organs all differ by at least 10 percentage points between standardized and crude versions. The rank order of rates also changes by at least eight for these sites.
The combined disagreement rates by center are shown in table 5. The directly standardized rates adjust for the effect of site. We used the number of cases by site for all centers combined as the standard. Center R has been dropped because of its small number of cases available for this analysis. The variation in standardized rates across centers in . This, along with the finding that site has a more statistically significant effect on disagreement rates than center, suggests that site is a more important factor than center in affecting disagreement rates. As noted earlier, the difference betwen the standardized and crude rates can be large. The rates for centers C and K change by over 10 percentage points and six to ten ranks when comparing the two types of rates.
Accuracy of Cancer Data 1011
Combined disagreement rates by stage for several of the more frequent sites and for all sites combined are shown in table 6. These rates have not been standardized. There is no one pattern that summarizes the stage coding across the individual sites. For example, for lung, distant stage has the highest rate, while for colon, local stage has the highest rate. For cervix, in situ stage has the lowest rate, while for female breast, in situ has a rate as high as or higher than the rates for other stages.
For all sites combined, the coding of local and regional stages is less accurate than the coding of in situ and distant stage. However, as is evident from the table, this ordering of rates may vary significantly by site. As pointed out earlier, the disagreement rate for coding unknown stage is extremely high.
DISCUSSION
This study has shown that in a large multicenter data collection program, basic cancer information can be coded and abstracted with moderate to excellent accuracy with the exception of stage. From a detailed review of cases, we also found that disagreements in coding overwhelmingly involved errors rather than justifiable differences in opinion. [This finding is consistent with our earlier study (5) .] Such discrepancies are usually due to coders' missing information.
Disagreements in the use of unknown codes were common and may also be due to coders' missing information. Certain prImary sites also had high disagreement rates.
The only item for which accuracy in CCPDS and in another data system can be compared is site. An error rate of 20% on a three-digit site code was quoted in 1978 by Demlo et al. (l) . This is considerably higher than the 7% major disagreement rate for a comparable three-digit code in the present study. CCPDS is a training-intensive organization, and its greater accuracy is probably a result of that. The CCPDS training program includes both centralized and on-site workshops. In addition, all centers receive answers to any coding questions of general interest.
We suggest the following standard procedure for identifying sources of disagreements. The standard procedure is more time-consuming than methods used in past evaluation studies; however, the procedure will serve as a clear guide for training effort. 1) Calculate crude disagreement rates by item (e.g., table 2) and by categories of an item (e.g., each stage of disease and each site). The rates by category of an item are important; some infrequently used categories of an item (e.g., rare sites) may have high disagreement rates that will be "washed out" when averaged with low rates for the common categories, yielding a low overall error rate for the item.
2) Items that are commonly used together (e.g., site, stage, and histology) can be grouped to calculate a group disagreement rate, as in table 3.
3) If there are a sufficient number of cases, disagreement rates also should be calculated by institution, coding uni t, or coder.
Steps 1-3 will initially identify some problem items or centers. (For example, in our study, coding problems were identified for unknown stage and at particular centers.) Usually, there will be a few key items that should be emphasized in the next steps. 4) Calculate standardized disagreement rates for categories of an item (e.g., each center or each site), as in tables 4 and 5, to adjust for confounding. We found that some sites had high crude disagreement rates simply because those sites were seen more frequently at centers that did less accurate coding. The standardized rate for site, controlling for center, removed this effect. A comparison of the standardized and crude rates in tables 4 and 5 shows that the crude rate can be misleading in a few cases. Fleiss (11) and others describe the method of standardization in clear terms.
5) A mathematical model for the effect of each of several items (e.g., site, stage, and center) on disagreement rates can be fit to the data. The logistic regression model is a good choice in this situation (13) . Standard statistical tests can be performed for differences in disagreement rates between categories of an item while adjusting for one or more confounding factors. Stratification by one item when testing for differences in disagreement rates between categories of another item also can be incorporated into the logistic regression model (12) . We did this type of analysis for the joint effect of center, site, and stage on disagreement rates. We found that all three factors significantly affected disagreement rates and that the effect of each factor was not spuriously due to confounding by the other factors.
The role of training with the use of procedures such as that just defined is critical, and the present study shows that good coding can be achieved. For example, some centers did have low disagreement rates, and the fact that variation in agreement rates by center was both large and statistically significant suggests that the low rates were not due to chance. We found that even for the most intractable item-stage-5 out of 22 centers had a major disagreement rate of 12% or less as compared to a rate of 23% for all centers combined.
A comment on methods of measuring quality of coding is possible by comparison of the results presented here, based on recoding of actual medical records, with the results of the related study by Feigl et al. (5) which involved most of the centers studied here. In the earlier study, standardized typed medical charts were presented to coders. For the eight key items, the present study has disagreement rates averaging 4 percentage points higher than the earlier study. Thus standardized charts cannot replace' real charts when one estimates disagreement rates. However, standardized charts can be a good tool for spotting coding problems.
In comparing studies or in designing a study of accuracy, it is important to clearly note the definition of accuracy used. In our study accuracy was measured by comparison of original codes from medical records to expert recodes. Another definition of accuracy is the correspondence of the information in the medical records to the actual state of the patient, as determined, for example, by autopsy. This type of accuracy has been studied less frequently, although the studies of Rosenblatt et al. (14) and Ehrlich et al. (15) are examples of autopsy studies where such accuracy was measured. Finally, accuracy is sometimes defined as reproducibility, i.e., the rate with which multiple coders agree on a code, which mayor may not be the correct code. Our earlier study (5) was, in part, a study of reproducibility.
We have found that the glib and often-heard notion that the complexity of medical records leads to a morass of contradictory interpretation is not true. In our experience well-defined items, even complex ones, can be accurately coded, provided sufficient resources are directed to that goal.
